UKUK

UK to channel EUR21m into regenerative medicine

16.07.2009

London – The UK’s Office for Life Sciences (OLS) will invest EUR21m into the development of stem cell therapies via its “Life Sciences Blueprint” programme. The move was welcomed by the Bioindustry Association (BIA). „ This funding provides a solid foundation on which the UK’s regenerative medicine industry can grow,” said Richard Archer, Chair of the BIA RegenMed Industry Group. On top of the funding the MRC, BBSRC and the PSRC will support the programme with an additional EUR4m funding.
According to the BIA, the package of measures provided by “Life Sciences Blueprint” will help the UK capitalise fully on its leading global position in regenerative medicine. The OLS’ blueprint sets out to transform the UK environment for life sciences companies and ensure faster patient access to cutting-edge medicines and technologies.
The measures include the introduction of "Innovation Pass", a 3-year initiative that will make selected innovative medicines available on the NHS for a time-limited period. The Pass will be piloted in 2010/2011 under the leadership of the National Institute for Health and Clinical Excellence (NICE), with a budget of EUR29m.
Additionally, UK government will reinforce the need for greater emphasis on research and clinical trials in the next NHS Operating Framework. Futhermore, UK policymakers will support the formation of a UK Life Sciences Super Cluster to co-ordinate work across industry, higher education and the NHS, and boost international recognition of UK life sciences.
In regenerative medicine, the UK is under pressure by world-class competitors located in Israel. At the end of June, Israel’s trade ministry set up a EUR45m capital fund for their biotech start-ups, which are to a good part active in RegenMed.

UKUK

22.12.2011

London - Nothing is well if the end is not well. For Astra Zeneca the end of 2011 isn't well at all. A new anti-ovarian cancer drug and a planned antidepressant have underperformed in tests. As a result, AstraZeneca will take a...

UKUK

17.12.2011

Surrey – The UK government is investing an additional £80m (€93.5m) to fund continued development of the Institute for Animal Health (IAH) at Pirbright, an institute of the Biotechnology and Biological Sciences Research Council...

UKUK

15.12.2011

Rijeka/London – Allergies like asthma or psoriasis might arise from environmental toxins, suggest researchers from Rijeka University (Croatia) and King’s College (London). In mice, they identified a special population of T cells...

UKUK

13.12.2011

London – Interesting times ahead in the European cancer treatment market. A report states that in the UK alone, diagnosis and treatment costs are likely to increase by 62%, from £9.4 billion in 2010 to £15.3 billion by 2021. The...

UKUK

12.12.2011

York - Tissue Regenix Group plc plans to raise €29m through the sale of 181.8 million shares. The regenerative medical device company is held within the IP Group portfolio and a spin-out company from the University of Leeds. The...

UKUK

11.12.2011

London – Cancer Research UK has begun recruiting patients in the first phase of its Stratified Medicine Programme, which is aimed at finding cancer biomarkers and establishing a genetic testing service in the UK. The charity’s...

UKUK

06.12.2011

London – British Prime Minister David Cameron is trying to come to the rescue of Britain’s embattled biopharmaceutical industry. He has earmarked €210m to support a “biomedical catalyst fund” to back early-stage academic and...

UKUK

06.12.2011

London - David Cameron plans to come to the rescue of Britain's embattled biopharmaceutical industry. The conservative prime minister has earmarked £180m (€210 million) to support a "biomedical catalyst fund" to back ...

UKUK

25.11.2011

Cancer Research UK has started recruiting patients in the first phase of its Stratified Medicine Program, which is seeking to find cancer biomarkers and establish a genetic testing service in the U.K. The charity's multi-million...

Displaying results 11 to 20 out of 396

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-uk/browse/1/article/uk-to-channel-eur21m-into-regenerative-medicine.html

Product of the week

Products

Events

All Events

Current issue

All issues